Detalhe da pesquisa
1.
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.
Proc Natl Acad Sci U S A
; 111(11): 4055-60, 2014 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-24591621
2.
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics.
J Biol Chem
; 287(13): 9742-9752, 2012 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-22223645
3.
Recommended quality measures for health-system pharmacy: 2019 update from the Pharmacy Accountability Measures Work Group.
Am J Health Syst Pharm
; 76(12): 874-887, 2019 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31361855
4.
Improving patient care and demonstrating value during a global pandemic: Recommendations from leaders of the Pharmacy Accountability Measures Work Group.
Am J Health Syst Pharm
; 77(23): 2003-2005, 2020 11 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32835361
5.
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status.
Front Mol Neurosci
; 7: 54, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25009464
6.
Functional characterization of an isoform-selective inhibitor of PI3K-p110ß as a potential anticancer agent.
Cancer Discov
; 2(5): 425-33, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22588880
7.
Quality improvement organizations and medication therapy management.
Am J Health Syst Pharm
; 63(13): 1219-20, 1222, 1224, 2006 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16790572